Coca-Cola proved to be the strongest US brand by posting a Brand Strength Index (BSI) score of 93.3, higher than Google, YouTube, Amazon, and Deloitte, according to a TradingPlatforms.com analysis.
The BSI rating also places Coca-Cola 2.2 points ahead of rival beverage company Pepsi.
The Brand Loyalty and Recommendation Forecast data, which reflects consumer perceptions, preferences, and intentions both online and offline, is the basis for the BSI score ranking.
Additionally, the renowned beverage business has a correspondingly prestigious AAA+ rating.
TradingPlatforms’ financial expert Edith Reads attributed Coca-Cola’s brand strength to the prominence of its core drink in the consumer’s mind, and recent innovations such as new flavors and lower sugar variants.
The BSI score, she continued, is a gauge of consumer loyalty, which can only be attained by having a remarkable level of brand awareness and high consumer approval ratings.
To satisfy consumer demand in a period of growing health consciousness, the company has concentrated on offering low-nutrition and alternative products like Coke Zero.
In a time of disrupted supply chains, it has also strategically chosen to use e-commerce to guarantee brand availability. In addition to its strong product strategy, which helped Coca-Cola ascend to the top, the company's digital strategy has also increased sales.


GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



